Site Map

• Home
• Clinical diagnostics
• Products
• Biological reference materials
• Sub category listing
• detail page
• Current influenza standards
• Quality control reagents
• CJD Resource Centre
• Result Reporting System (RRS)
• Centre for AIDS Reagents
• My Account
• Complete product list
• Reference Standards
• WHO established products 2010
• WHO established products 2011
• WHO established products 2012
• Ordering Information
• Problems ordering
• Importing Biological Materials
• Frequently Asked Questions
• Search Catalogue
• Ordering
• Apply for an account
• Thank you
• New Account
• View previous orders
• Place an order
• Shopping basket
• Price list
• Latest standards
• Standardisation
• History of standardisation
• International standards
• International reference reagents
• Working standards
• IVD standards
• Standards
• Importance of GRM
• Collaborations and Commercial Impact
• GRM team
• Platelets
• Modelling chronic viral diseases
• Modelling chronic viral diseases
• Control testing
• Control testing price list
• Logout
• Independent batch release testing at the NIBSC
• Shipping instructions for independent batch release testing
• Science and research
• Advanced therapies
• Cell substrates for viral vaccines
• Gene therapy
• Genomic reference materials
• In-development WHO International Standards for Cancer Genomics
• BCR-ABL (WHO)
• JAK2 V617F (WHO)
• KRAS (WHO)
• Factor V Leiden (WHO)
• Factor VIII Intron 22 Inversion (Haemophilia A; WHO)
• Prothrombin G20210A (Factor II; WHO)
• Fragile X (WHO)
• Prader Willi and Angelman (WHO)
• RhD SRY Plasma DNA (WHO)
• Lynch-HNPCC(MLH1-MSH2; CE)
• Red Blood Cell Genotyping (WHO)
• Ordering NIBSC Genomic Reference Materials
• NGS Validation Challenge Samples
• WHO 1st International Standards for Cancer Genomes
• HCT 15
• ATDB102
• MOLT-4
• Proposed first WHO International Standards for EGFR variants
• UK Stem Cell Bank
• Cell Lines Catalogue
• EUTCD Grade Cell Lines
• Qualified Mouse Embryo Fibroblasts
• Research grade stem cell lines
• Apply for cell lines
• Policies guidelines and due diligence
• Deposit stem cell lines
• UK Stem Cell Bank research
• UK Stem Cell Bank facilities
• Transfer, import or export stem cells
• Patent Depositary Service
• Application forms
• Virology
• Polio
• Polio surveillance and quality control of polio vaccines
• Polio impact story
• New polio vaccines
• Inactivated viral vaccines
• Peptide Library
• Spleen Homogenates
• WHO Reference Reagents
• Brain protein 1433
• Virtual Resources
• Sheep Samples
• Cow Samples
• Plasma Panel
• Special Samples
• Influenza Resource Centre
• Influenza standardisation
• Seasonal influenza
• Influenza potency testing
• Pandemic influenza
• Influenza research
• Full reagent update
• CFAR blog
• AIDS Reagents catalogue
• Product details
• Live viral vaccines
• Live viral vaccines (Rose group)
• Live viral vaccines (Schepelmann group)
• Establishment of the first WHO International Standard for anti-Rift Valley fever virus antibodies
• Bacteriology
• Anthrax
• Botulinum
• Cholera
• Clostridioides difficile
• Diphtheria
• Group A Streptococcus
• Group B Streptococcus
• Haemophilus influenzae b (Hib)
• Malaria
• Meningococcal disease
• Pertussis
• Tuberculosis and BCG
• Pneumococcal disease
• Physico-chemical analysis
• Sexually transmitted infections
• Tetanus
• Shigella
• Typhoid
• Biotherapeutics
• Cytokines and Growth factors
• Endocrinology
• Haemostasis
• Haemostasis standards
• Haemostasis control testing
• Haemophilia A and Factor VIII
• Coagulation factors
• Coagulation factor standards and new therapeutics for bleeding disorders
• Fibrinolysis
• Molecular Immunology
• Therapeutic immunoglobulins and Allergens
• Human Albumin Solutions
• Monoclonal antibodies
• Blood cell and platelet immunology
• Cellular Immunology
• Immunotoxicology
• Pyrogenic pro-inflammatory activities
• Flow Cytometry Reference Materials
• New and existing standards
• New Page
• Analytical sciences
• Mass spectrometry and proteomics
• Recombinant proteins
• Method performance standards
• Standardisation sciences
• Biostatistics
• Glycan analysis
• Imaging sciences
• Bioinformatics and NGS
• Infectious Disease Diagnostics
• Standards and reference materials
• SoGAT
• Plasma pool testing
• CJD Research and Resource Centre
• CJD test evaluation
• Amyloid research
• CJD reference reagents
• Centre for AIDS Reagents
• AIDS Reagents catalogue
• Product details
• Ordering from CFAR
• Donating to CFAR
• COVID-19-related research reagents
• History of CFAR
• Modelling vaccines against HIV/AIDS
• Supporting vaccine development for Emerging Diseases
• Microbiome
• A to Z listing
• Publications
• 2016 publications
• 2017 Publications
• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• CFAR
• Modelling vaccines against HIV/AIDS
• Standardisation of Genome Amplification Techniques
• Expert services
• Customised biological materials
• Contract testing
• Scientific and regulatory advice
• Training and events
• Heparin Workshop
• UKSCB training workshop
• About us
• Latest news
• New QCRU CE-marked Measles, Mumps and Lyme disease run controls
• NIBSC Ebola reference reagents endorsed as global standards by WHO
• New NIBSC director
• NIBSC develops new-CE marked virus triplex for NAT PCR blood testing – HBC, HCV, HIV
• Launch of £10m collaborative research project
• New international consensus on pluripotent stem cells as starting materials
• 6th Heparin Workshop on the characterisation of heparin Products
• Vaccination against influenza
• NIBSC experts at paediatric typhoid vaccine workshop
• New and replacement WHO international standards available
• OCABR batch release certificates
• NIBSC signs agreement with UCL
• New result reporting software
• Scientific Review of NIBSC chaired by Professor Sir Patrick Sissons published
• NIBSC contributes to global flu vaccination effort
• NIBSC merges with MHRA
• New research on polio published
• Margaret Chan
• Winter newsletter
• CE-marked Clinical Virology Multiplex I
• Directors Statement on the EU Referendum Result
• MHRA statement on outcome of EU referendum
• NIBSC part of VAC2VAC consortium
• Supporting the Global Supply of Oral Cholera Vaccines
• Promoting biological standardisation – NIBSC and NIFDS sign MoU
• New technique could enable safer production of polio vaccines
• NIBSC and TGN1412
• ‘Regulator ready’ stem cell lines now available for clinical development
• Making new polio vaccines with plants
• TRANSVAC2
• 1st WHO International Standard
• New strategy to end Cholera
• New WHO international genomic reference panel for KRAS cancer mutations
• Fighting malaria resistance
• Supporting the use of typhoid conjugate vaccines
• New UK Centre of Excellence for Engineering Biology, Metrology and Standards announced
• WHO endorses new International Standard for malaria diagnosis
• Improving our ordering process
• New grant to ensure safety of cell therapies
• NIBSC support meeting on cholera vaccine standardisation
• Knowledge Transfer Partnership 2018
• New Infliximab and Rituximab standards
• UK Stem Cell Bank awarded MRC grant
• NIBSC deliver webinar with IBMS on quality control materials
• NIBSC win Lassa fever vaccines grant
• Typhoid meeting
• Innovate UK AMR grant
• World Malaria Day 18
• NGS technique for polio surveillance
• Biological reference materials in no deal scenario
• Lassa biostandards kick-off meeting
• Changes to NIBSC ordering
• Towards animal free cell-based tests for ensuring the safety of vaccines
• Biological medicine quality to receive major boost
• NIBSC at The Institute of Biomedical Science Congress 2019
• Latest mAb research
• Guidance for manufacturers of biological medicines
• Recommended vaccine strains for the southern hemisphere 2020 flu season announced
• Adalimumab standard
• HPV standards
• DCVMN training
• Update on official control authority batch release (OCABR) testing following the extension to Article 50
• Polio update
• ECBS meeting
• blood tubes
• Novel coronavirus update
• Transition period update
• iPSC Workshop 2020
• Cancer genome standard
• COVID-19 Research Reagent
• COVID-19 Antibody Reagent
• COVID-19 run control for NAT
• nOPV Vaccine Study
• Standardisation and COVID-19
• COVID-19 Serology EQC Reagent
• Nanobodies and influenza
• Microbiome standards
• Standardised typhoid vaccine assay
• TRANSVAC-DS
• Website announcement
• COVID antibody diagnostic calibrant
• Shigella and GBS Standards
• COVID-19 vaccine testing
• Coronavirus environmental surveillance
• World Antimicrobial Awareness Week
• MHRA approves covid-19 vaccine
• Winter multiplex diagnostic control
• Independent batch release testing of COVID-19 (coronavirus) vaccines
• NIBSC statement on batch testing for the COVID-19 Vaccine AstraZeneca
• ECBS 2020
• CFAR update
• M4R
• New mAb International Standards
• CRA reference panel
• NIBSC to support pioneering gene therapy centre
• Request for collaboration
• Using environmental surveillance to track coronavirus variants
• Prime Minister kicks off major new science initiative at visit of MHRA’s National Institute for Biological Standards and Control
• Evette ‘people’s choice’ winner
• SoGAT forum
• UK Stem Cell Bank secures National Institute for Health Research grant
• TRANSVAC-DS: Towards a sustainable European vaccine infrastructure
• Our development of the MAT supports the safe testing of novel vaccines
• Using proteomics to understand survival during meningococcal outbreak
• New range of reference standards
• Changes to the look of our website
• NIBSC polio vaccine nOPV2 recommended for wider use
• Using environmental surveillance to track the most recent coronavirus variant AY.4.2
• Pay NIBSC invoices easily
• Our First WHO International Standard (IS) for Harmonizing the Biological Activity of Bevacizumab
• Regulators Pioneer Funded Project 2021-2022
• Unique opportunity for healthcare professionals to influence future MHRA safety communications and safety reporting systems
• Research reagent for Mpox antibodies now available
• NIBSC Reference Reagent for DNA extraction of gut microbiome samples
• International Women’s Day – meet the women at the forefront of STEM
• Happy 75th Anniversary to the World Health Organization
• New MHRA cell therapy research evaluates immune-stimulant cancer therapies to reduce side effects for patients
• New NIBSC reference materials available
• New panel of antibodies specific to SARS-CoV-2 variants available for vaccine researchers
• Changes to customer log in process
• Worldwide impact of NIBSC
• Responding to incidents
• The Eradication of Polio
• Vaccines against Bacterial Meningitis
• TGN1412
• Influenza
• Mission and values
• Careers
• PhD Studentships
• Quality and governance
• Staff profiles
• Dr Simon E. Hufton
• Dr Jillian Cooper
• Dr Sjoerd Rijpkema
• Dr Paul Bowyer
• Dr Fatme Mawas
• Dr Mei Mei Ho
• Dr Debbie Ferguson
• Dr Barbara Bolgiano
• Dr Dianna E. Wilkinson
• Dr Mark Page
• Dr Neil Berry
• Dr Nicola Rose
• Dr Sarah Gilbert
• Dr Silke Schepelmann
• Clare Morris
• Dr Rob Anderson
• Peter Rigsby
• Dr Paul Matejtschuk
• Dr Chris Burns
• Dr Jun Wheeler
• Dr Anthony Hubbard
• Dr Carl Dolman
• Dr Colin Longstaff
• Dr Sanj Raut
• Dr Paul Metcalfe
• Dr Ross Hawkins
• Dr Meenu Wadhwa
• Dr Yuan Zhao
• Dr Chris Jones
• Dr Elaine Gray
• Dr Neil Almond
• Dr Sandrine Vessillier
• Dr Kevin Markey
• Dr Hannah Chan
• Caroline Vipond
• Dr Javier Martin
• Dr Andrew Macadam
• Dr Othmar Engelhardt
• Dr Rory Care
• Sandra S. Diebold
• Dr Christian Schneider
• Dr Elsa Abranches
• Carmen Coxon
• Bernard Fox
• Dr Craig Thelwell
• Dr Stella Williams
• Dr John Hogwood
• Dr Sandra Prior
• Dr Ben Cowper
• Dr Melanie Moore
• Francesco Lescai
• Helen Wilmot
• Martin Fritzsche
• Dr Tim Rudd
• Dr Anna Nowocin
• Dr Paul Stickings
• Dr Bhagwati Khatri
• Dr Donna Bryan
• Dr Alexandra Shaw
• Dr Chrysi Sergaki
• Dr Fang (Frank) Gao
• Dr Nicola Beresford
• Evette Hillman
• Dr Jason Long
• Contact us
• Collaborations
• Suppliers
• Instructions for shipping to MHRA/NIBSC
• Scientific Advisory Committee
• Minutes of the Animal Welfare and Ethical Review Body
• 12 January 2022
• 15 February 2022
• 15 March 2022
• 8 April 2022
• 13 April 2022
• 10 May 2022
• 12 September 2022
• AWERB Minutes February 2020
• AWERB Minutes August 2020
• AWERB Minutes October 2020
• AWERB Minutes December 2020
• AWERB Minutes February 2021
• AWERB Minutes March 2021
• June 2021
• AWERB minutes - 2021
• AWERB minutes - 2020
• September 2021
• October 2021
• 16 November 2021
• 23 November 2021
• Our use of animals
• Animal welfare
• The 3Rs
• Regulation of animal use
• Number and type of animals
• Privacy notice
• Centre for AIDS Reagents
• Reagent Listings
• My Account
• Shopping basket
• careers
• sitemap
• accessibility
• Cookie information
• UKSCB homepage draft
• Our cell lines
• EUTCD-grade human embryonic cell lines
• Apply for cell lines
• Deposit stem cell lines
• UKSCB research